| Code | CSB-RA983870A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
DHX9, also known as RNA helicase A or Nuclear DNA helicase II, is an ATP-dependent DEAH-box helicase that plays essential roles in transcriptional regulation, DNA replication, and genome stability. This multifunctional enzyme unwinds both DNA and RNA duplexes and participates in diverse cellular processes including R-loop resolution, innate immune responses, and the maintenance of genomic integrity. DHX9 has emerged as a significant target in cancer research, where its dysregulation has been linked to tumor progression and therapeutic resistance, making it a compelling focus for oncology and cell biology investigations.
This recombinant monoclonal antibody, clone 14F8, offers researchers the reproducibility and consistency that recombinant technology provides. Generated against a synthetic peptide derived from human DHX9, this sequence-defined antibody ensures reliable performance across experiments and eliminates the lot-to-lot variability often encountered with traditional hybridoma-derived antibodies.
Validation studies demonstrate robust performance across multiple applications. Immunohistochemistry testing in paraffin-embedded human lung cancer and small intestine tissues at 1:100 dilution reveals clear detection using citrate buffer antigen retrieval, providing researchers with optimized starting conditions for tissue-based studies. Immunofluorescence analysis in A549 cells shows distinct nuclear localization patterns consistent with DHX9's known subcellular distribution. Flow cytometry validation using Raji cells confirms the antibody's utility for single-cell analysis, with clear separation between specific signal and isotype control populations.
This antibody supports researchers investigating DNA damage responses, transcriptional regulation, and cancer biology, offering workflow flexibility across immunohistochemistry, immunofluorescence, flow cytometry, and ELISA platforms for comprehensive DHX9 characterization in human samples.
There are currently no reviews for this product.